Shuai Zhao

Shuai Zhao

Auto-generated profile, based on publicly available information

Shuai Zhao

Baylor College of Medicine

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2025 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
BKBharat K. Kantharia
Bharat K. Kantharia
SZShuai Zhao
Shuai Zhao
Dominik LinzDominik Linz
Dominik Linz
JHJordi Heijman
Jordi Heijman
Xander WehrensXander Wehrens
Xander Wehrens

1 November 2025 in American Journal of Physiology-Heart and Circulatory Physiology
Verified
Journal Article
Closed access
KHKevin Ho
Kevin Ho
JKJoshua A. Keefe
Joshua A. Keefe
SZShuai Zhao
Shuai Zhao
MHMohit Hulsurkar
Mohit Hulsurkar
SJSung Yun Jung
Sung Yun Jung
Xander WehrensXander Wehrens
Xander Wehrens
Our study reveals a rare MRC2 gene variant (E990G) linked to familial supraventricular tachycardia and Wolff–Parkinson–White syndrome increases atrial fibrillation (AF) susceptibility in mice. The E990G-heterozygous variant disrupts atrial cardiofibroblast function, reducing protective matrix metalloproteinases (MMP-12 and MMP-13) and elevating profibrotic CCN2/CTGF levels, as shown through transcriptomic and proteomic profiling. This suggests that MRC2 deficiency promotes AF by altering fibrotic regulation in atrial tissue.

5 August 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
SZShuai Zhao
Shuai Zhao
SBSiena Bush
Siena Bush
IRIvan O. Rosas
Ivan O. Rosas
SRSvetlana Reilly
Svetlana Reilly
Xander WehrensXander Wehrens
Xander Wehrens
Gla proteins are a vitamin K–dependent family long studied for their roles in blood clotting and vascular calcification. This review examines their broader involvement in cardiovascular disease, particularly cardiac fibrosis. We highlight that their functions are context-dependent, varying with disease stage and cellular environment, and that several occur independently of γ-carboxylation, challenging the view that this modification is universally required for their function. By comparing fibrosis across the heart, lung, liver, and kidney, we distinguish shared from organ-specific mechanisms. Finally, we discuss prospective therapies, from vitamin K supplementation to receptor-targeted approaches, and the questions that remain before clinical translation.